These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22582493)

  • 1. Increased urinary type II collagen C-telopeptide levels in Tunisian patients with knee osteoarthritis.
    Kalai E; Bahlous A; Charni N; Bouzid K; Sahli H; Chelly M; Meddeb M; Zouari B; Abdelmoula J; Sellami S
    Clin Lab; 2012; 58(3-4):209-15. PubMed ID: 22582493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.
    Jung M; Christgau S; Lukoschek M; Henriksen D; Richter W
    Pathobiology; 2004; 71(2):70-6. PubMed ID: 14707441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey.
    Tanishi N; Yamagiwa H; Hayami T; Mera H; Koga Y; Omori G; Endo N
    J Bone Miner Metab; 2009; 27(5):605-12. PubMed ID: 19381754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey.
    Tanishi N; Yamagiwa H; Hayami T; Mera H; Koga Y; Omori G; Endo N
    J Orthop Sci; 2014 May; 19(3):429-36. PubMed ID: 24504986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.
    Dam EB; Byrjalsen I; Karsdal MA; Qvist P; Christiansen C
    Osteoarthritis Cartilage; 2009 Mar; 17(3):384-9. PubMed ID: 18768336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between CTX-II and patient characteristics, patient-reported outcome, muscle strength, and rehabilitation in patients with a focal cartilage lesion of the knee: a prospective exploratory cohort study of 48 patients.
    Røtterud JH; Reinholt FP; Beckstrøm KJ; Risberg MA; Arøen A
    BMC Musculoskelet Disord; 2014 Mar; 15():99. PubMed ID: 24661577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis.
    Mazzuca SA; Brandt KD; Eyre DR; Katz BP; Askew J; Lane KA
    Ann Rheum Dis; 2006 Aug; 65(8):1055-9. PubMed ID: 16339292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of type II collagen fragments and X-ray progression of knee osteoarthritis].
    Kalaï E; Bahlous A; Bouzid K; Laadhar L; Cheour E; Sellami S; Abdelmoula J; Sahli H; Chelly M
    Ann Biol Clin (Paris); 2014; 72(6):715-21. PubMed ID: 25486667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
    Garnero P; Aronstein WS; Cohen SB; Conaghan PG; Cline GA; Christiansen C; Beary JF; Meyer JM; Bingham CO
    Osteoarthritis Cartilage; 2008 Jun; 16(6):660-6. PubMed ID: 17993283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between urinary C-telopeptide fragments of type II collagen and knee structure in middle-aged women without clinical knee disease.
    Wang B; Pramono HK; Cicuttini FM; Hanna F; Davis SR; Bell RJ; Wang Y
    Osteoarthritis Cartilage; 2014 Aug; 22(8):1136-41. PubMed ID: 24971869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.
    Deberg MA; Labasse AH; Collette J; Seidel L; Reginster JY; Henrotin YE
    Osteoarthritis Cartilage; 2005 Dec; 13(12):1059-65. PubMed ID: 16154771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
    Bruyere O; Collette J; Kothari M; Zaim S; White D; Genant H; Peterfy C; Burlet N; Ethgen D; Montague T; Dabrowski C; Reginster JY
    Ann Rheum Dis; 2006 Aug; 65(8):1050-4. PubMed ID: 16396978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects.
    Kumm J; Tamm A; Lintrop M; Tamm A
    Rheumatol Int; 2013 Apr; 33(4):903-11. PubMed ID: 22821260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
    Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
    Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis.
    Huebner JL; Bay-Jensen AC; Huffman KM; He Y; Leeming DJ; McDaniel GE; Karsdal MA; Kraus VB
    Arthritis Rheumatol; 2014 Sep; 66(9):2440-9. PubMed ID: 24909851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Arlot M; Christiansen C; Delmas PD
    Arthritis Rheum; 2004 Oct; 50(10):3137-44. PubMed ID: 15476251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Analysis of C-terminal telopeptide of collagen type II and Interleukin-1β for Early Diagnosis of Knee Osteoarthritis.
    Liu CX; Gao G; Qin XQ; Deng CQ; Shen XJ
    Orthop Surg; 2020 Feb; 12(1):286-294. PubMed ID: 31840428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.